These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2158911)

  • 1. [The significance of cGMP and dopamine receptor on the natriuretic and hypotensive activities of synthetic atrial natriuretic polypeptide in essential hypertension].
    Mori K; Shigetomi S; Kohno H; Tosaki H; Kato K; Tanaka K; Haga H; Kin S; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1990 Feb; 66(2):83-93. PubMed ID: 2158911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension].
    Mori K
    Nihon Naibunpi Gakkai Zasshi; 1991 Jul; 67(7):796-810. PubMed ID: 1653713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].
    Iannettone CM; Strazzulla G; Fabbri G; Piazza E; Valenza T; De Feo ML; Franchi F
    Ann Ital Med Int; 1991; 6(3):273-83. PubMed ID: 1837999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular, renal and endocrine effects of alpha-human atrial natriuretic peptide in patients with Cushing's syndrome and primary aldosteronism.
    Fujio N; Ohashi M; Nawata H; Kato K; Matsuo H; Ibayashi H
    J Hypertens; 1989 Aug; 7(8):653-9. PubMed ID: 2553806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension.
    Weidmann P; Gnädinger MP; Ziswiler HR; Shaw S; Bachmann C; Rascher W; Uehlinger DE; Hasler L; Reubi FC
    J Hypertens Suppl; 1986 Jun; 4(2):S71-83. PubMed ID: 2941546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the renin-aldosterone system and atrial natriuretic polypeptide in rats.
    Hirata Y; Ishii M; Sugimoto T; Matsuoka H; Ishimitsu T; Atarashi K; Sugimoto T; Miyata A; Kangawa K; Matsuo H
    Clin Sci (Lond); 1987 Feb; 72(2):165-70. PubMed ID: 2949908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
    Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
    J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Joyce SL; Gilchrist NL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):946-53. PubMed ID: 2943757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-human atrial natriuretic polypeptide-induced rise of plasma and urinary cyclic 3'5'-guanosine monophosphate concentration in human subjects.
    Ohashi M; Fujio N; Nawata H; Kato K; Ibayashi H
    Clin Exp Hypertens A; 1986; 8(1):67-73. PubMed ID: 3011321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of intravenous injection of alpha-human atrial natriuretic polypeptide on blood pressure, renal hemodynamics and urinary kinin excretion in anesthetized rabbits.
    Nushiro N; Abe K; Seino M; Omata K; Yoshinaga K
    Tohoku J Exp Med; 1987 Feb; 151(2):221-31. PubMed ID: 2953089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-human atrial natriuretic polypeptide reduces the plasma arginine vasopressin concentration in human subjects.
    Fujio N; Ohashi M; Nawata H; Kato K; Ibayashi H; Kangawa K; Matsuo H
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):181-7. PubMed ID: 3024877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
    J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic action of ANP is blunted by ACE inhibition in humans.
    Wambach G; Schittenhelm U; Stimpel M; Bönner G; Kaufmann W
    J Cardiovasc Pharmacol; 1989 May; 13(5):748-53. PubMed ID: 2472523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natriuretic and hypotensive effects of alpha-human atrial natriuretic polypeptide in anaesthetized DOCA-salt hypertensive rats.
    Kondo K; Kida O; Kangawa K; Matsuo H; Tanaka K
    Clin Exp Pharmacol Physiol; 1986 Feb; 13(2):97-101. PubMed ID: 2940041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of phenylephrine on atrial natriuretic factor and the renin-aldosterone axis in normal patients and essential hypertensive patients].
    Closas J; Genest J; Larochelle P; Cusson J; Gutkowska J; Hamet P; De Léan A; Thibault G; Cantin M
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():75-8. PubMed ID: 2847676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for an involvement of dopamine receptors in the natriuretic response to atrial natriuretic peptide.
    Marin-Grez M; Angchanpen P; Gambaro G; Schnermann J; Schubert G; Briggs JP
    Klin Wochenschr; 1987; 65 Suppl 8():97-102. PubMed ID: 2955166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal application of atrial natriuretic peptide and 1-deamino-d-arginine vasopressin in healthy volunteers. Hemodynamic, hormonal, and renal excretory effects.
    Predel HG; Kuklinski P; Kramer HJ
    Am J Hypertens; 1992 Sep; 5(9):657-60. PubMed ID: 1329853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.